Myeloid lineage contributes to pathological choroidal neovascularization formation via SOCS3

Tianxi Wang1, Pingzhu Zhou2, Xuemei Xie3

  • 1Department of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.

Ebiomedicine
|October 23, 2021
PubMed
Abstract

Insights

Suppressor of cytokine signaling 3 (SOCS3) in myeloid cells regulates pathological neovascularization in age-related macular degeneration. Enhancing SOCS3 function inhibits neovascular growth and inflammation, offering a potential therapeutic target for vision loss.

Area of Science:

  • Ophthalmology
  • Immunology
  • Vascular Biology

Background:

  • Neovascular age-related macular degeneration (nAMD) causes significant vision loss in the elderly due to pathological neovascularization.
  • Myeloid lineage cells are increasingly recognized for their role in regulating pathological blood vessel formation.
  • The Suppressor of Cytokine Signaling 3 (SOCS3) pathway is implicated in neovascularization processes.

Purpose of the Study:

  • To investigate the role of myeloid SOCS3 in the pathogenesis of neovascular age-related macular degeneration (nAMD).
  • To elucidate the mechanisms by which myeloid SOCS3 influences pathological choroidal neovascularization (CNV).

Main Methods:

  • Utilized a laser-induced CNV mouse model to study nAMD.
  • Employed cell lineage reporter mice, bone marrow chimeric mice, and Socs3 knockout/overexpression models.
  • Applied immunohistochemistry, confocal microscopy, and choroidal explant co-cultures to analyze myeloid SOCS3 function.

Main Results:

  • SOCS3 expression was elevated in myeloid cells within CNV lesions.
  • Overexpression of myeloid SOCS3 inhibited CNV formation and reduced inflammatory cell infiltration.
  • SOCS3 modulated myeloid cell-driven vascular sprouting in vitro and SOCS3 agonists reduced in vivo CNV.

Conclusions:

  • Myeloid lineage cells, regulated by SOCS3, play a critical role in pathological CNV development.
  • Targeting myeloid SOCS3 represents a potential therapeutic strategy for nAMD.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K